금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Stocks Rise Pre-Bell as Traders Await Fed Policy Decision, Inflation Report, Big Tech Earnings
The benchmark US stock measures pointed higher before the opening bell Monday as traders gear up for...
Stock market today: Dow, S&P 500, Nasdaq futures rise ahead of busy week of earnings, Fed rate decision
Investors braced for a full earnings docket and the Federal Reserve's next policy decision this week...
British Pound: Stronger PMIs lean hawkish for BoE – Danske Bank
Danske Research Team notes UK flash PMIs strengthened in October, with the composite rising to 53.1 ...
British Pound: Consolidation with limited upside scope against US Dollar – UOB
United Overseas Bank’s (UOB) Quek Ser Leang and Lee Sue Ann analysts report GBP/USD traded quietly between 1.3423 and 1.3456 after a prior spike to 1.3506. They expect near‑term consolidation in a 1.3 ...
Euro holds gains against the Pound awaiting Eurozone and UK Services PMIs
The Euro (EUR) remains practically flat against the British Pound (GBP) on Wednesday, trading at 0.8573 at the time of writing and holding gains from the last two days after bouncing from the 0.8540 a ...
Russian bombardment kills 17 in Kyiv
Ukraine warns Patriot interceptor stocks are running low as retaliatory 40-day air campaign expires
Japanese Yen: Joint action fails to secure lasting gains – Commerzbank
Commerzbank’s Thu Lan Nguyen argues that the recent historic intervention in USD/JPY, powered by US Treasury participation, may not secure a lasting Japanese Yen (JPY) recovery.
Honda Motor GAAP EPS of ¥115.84, revenue of ¥6061.51B; updates FY 2027 outlook
France Industrial Output (MoM) registered at 0.1%, below expectations (0.3%) in June
Twist Bioscience prices upsized $300M equity at $96 per share
Forex Today: US Dollar struggles as risk flows dominate markets
Here is what you need to know on Wednesday, August 5:
Equities: Rally extends on reduced downside fears – Danske Bank
Danske Research Team describes a strong global equities session driven by reduced downside risks rather than upgraded growth expectations. Easing concerns over the Iran conflict and the AI bubble comp ...
Astellas Pharma ADR GAAP EPS of ¥78.96, revenue of ¥640.91B; reaffirms FY 2027 outlook